Cyclo(Arg-Pro) (TFA)

Cyclo(Arg-Pro) (TFA)

• UNSPSC Description: Cyclo(Arg-Pro) (Cyclo(Pro-Arg)) TFA is a chitinase inhibitor. Cyclo(Arg-Pro) TFA inhibits cell separation of Saccharomyces cerevisiae, without affecting its growth. Cyclo(Arg-Pro) TFA inhibits the morphological change of Candida albicans from yeast form to filamentous form[1].
• Target Antigen: Parasite
• Type: Peptides
• Related Pathways: Anti-infection
• Applications: COVID-19-immunoregulation
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/cyclo-arg-pro-tfa.html
• Purity: 98.04
• Solubility: H2O : 100 mg/mL (ultrasonic)
• Smiles: N/C(N)=N\CCC[C@@H]1NC([C@@](CCC2)([H])N2C1=O)=O.O=C(O)C(F)(F)F
• Molecular Weight: 367.32
• References & Citations: [1]Izumida H, et al., The effect of chitinase inhibitors, cyclo(Arg-Pro) against cell separation of Saccharomyces cerevisiae and the morphological change of Candida albicans. J Antibiot (Tokyo). 1996 Aug;49(8):829-31.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported